Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
May 06, 2020	RYAN ARTHUR F Director Trans History: 547	Director	Form 4	Open market or private sale of non-derivative or derivative security	1,260	$543.12	75,610
Jun 21, 2021	YANCOPOULOS GEORGE Director, President and Chief Scientific Trans History: 673	Director, President and Chief Scientific	Form 4	Open market or private sale of non-derivative or derivative security	2,276	$543.13	2,108
Sep 21, 2020	GOLDSTEIN JOSEPH L Director Trans History: 381	Director	Form 4	Open market or private sale of non-derivative or derivative security	300	$543.19	21,917
Dec 10, 2015	BROWN MICHAEL S Director Trans History: 466	Director	Form 4	Open market or private sale of non-derivative or derivative security	100	$543.55	2,900
Dec 02, 2015	YANCOPOULOS GEORGE Director, President Regeneron Laboratori Trans History: 673	Director, President Regeneron Laboratori	Form 4	Open market or private sale of non-derivative or derivative security	602	$543.57	541,648
Nov 17, 2020	MURPHY ANDREW J EVP Research Trans History: 222	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	467	$543.65	49,144
Nov 17, 2020	MURPHY ANDREW J EVP Research Trans History: 222	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	68	$544.01	49,076
Dec 10, 2015	BROWN MICHAEL S Director Trans History: 466	Director	Form 4	Open market or private sale of non-derivative or derivative security	100	$544.03	2,800
Dec 02, 2015	YANCOPOULOS GEORGE Director, President Regeneron Laboratori Trans History: 673	Director, President Regeneron Laboratori	Form 4	Open market or private sale of non-derivative or derivative security	4,290	$544.52	537,358
Nov 02, 2020	RYAN ARTHUR F Director Trans History: 547	Director	Form 4	Open market or private sale of non-derivative or derivative security	20	$544.54	23,823

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media